Storen Legacy Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$261K Buy
998
+7
+0.7% +$1.85K 0.07% 99
2026
Q2
$219K Buy
991
+215
+28% +$59.5K 0.06% 103
2026
Q1
$229K Hold
776
– – 0.07% 96
2025
Q4
$212K Buy
+776
New +$211K 0.07% 71

Other funds holding CME

Storen Legacy Partners's CME Position: Q3 2026 in Review

Storen Legacy Partners increased its CME Group (CME) stake by 0.71% in Q3 2026, buying an estimated $1.85K and bringing the position to 998 shares worth $261K. The position accounts for 0.07% of the portfolio, ranked #99.

Storen Legacy Partners first reported a position in CME in Q4 2025 and has held it in 4 quarters since. 1,767 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Storen Legacy Partners held 998 shares of CME Group worth $261K as of Q3 2026.
  • Storen Legacy Partners bought 7 CME Group shares in Q3 2026, an estimated $1.85K.
  • CME Group made up 0.07% of Storen Legacy Partners's portfolio in Q3 2026, its #99 holding.
  • Storen Legacy Partners first reported a position in CME Group in Q4 2025 and has held it in 4 quarters since.
  • 1,767 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Storen Legacy Partners's 13F filing for Q3 2026, filed 9 Nov 2026.